DCF — TEXAS HEALTH DALLAS
Enterprise Value: $-323.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-323.8M
Enterprise Value
$-120.2M
PV of Cash Flows
$-203.6M
PV of Terminal Value
$-327.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $731.9M | $-10.5M | -1.0% | $-41.4M | $-37.7M |
| Year 2 | $753.9M | $-3.2M | -0.0% | $-35.1M | $-29.0M |
| Year 3 | $776.5M | $4.4M | 1.0% | $-28.4M | $-21.4M |
| Year 4 | $799.8M | $8.6M | 1.0% | $-25.3M | $-17.3M |
| Year 5 | $823.8M | $10.9M | 1.0% | $-24.0M | $-14.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-323.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$710.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.019289347736462934
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5